ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.17
      -0.25%
      US Tech 100
      19,288.80
      -0.62%
      Dow Jones
      39,134.76
      0.77%
      Brent Oil
      85.00
      -0.01%
      Bitcoin
      64,578.57
      -0.37%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kymera Therapeutics Inc (KYMR)

      7. Kymera Therapeutics Inc (KYMR) Financials

      Kymera Therapeutics Inc

      Kymera Therapeutics Inc (KYMR)

      NASDAQ
      31.27
      0.07
      (0.22%)
      Closed June 21 4:00PM
      Delayed by 15 minutes
      31.27
      -0.04
      (-0.13%)
      After Hours: 4:05PM
      Delayed by 15 minutes

      Kymera Therapeutics Inc Financial Summary

      The current KYMR market cap is 1.91B. The company's latest EPS is USD -2.4048 and P/E is -13.02.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 9.47M16.51M4.73M47.89M10.29M
      Operating Income -45.33M-43.38M-57.51M-19.31M-52.91M
      Net Income -40.93M-38.8M-52.87M-14.37M-48.56M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.93M34.03M72.83M46.83M78.59M
      Operating Income -42.21M-46.3M-100.53M-161.26M-165.53M
      Net Income -41.25M-54.64M-100.22M-154.81M-146.96M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 613.91M581.95M552.38M575.76M868.25M
      Total Liabilities 151.9M146.52M156.84M180.79M157.05M
      Total Equity 462.01M435.43M395.54M394.97M711.2M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 116.7M487.18M605.91M603.13M575.76M
      Total Liabilities 82.03M203.29M146.27M112.98M180.79M
      Total Equity -74.41M283.89M459.64M490.15M394.97M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -43.97M-79.22M-110.87M-102.83M-39.59M
      Investing 24.58M60.42M120.93M139.89M-330.61M
      Financing 1.16M2.46M2.26M4.19M353.76M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 17.91M88.13M-128.95M-153.09M-102.83M
      Investing -16.49M-422.59M-99.84M20.52M139.89M
      Financing 34.91M289.26M250.28M153M4.19M

      Stats and Ratios

      Market Cap 1.91B
      Price to Earnings Ratio -13.02
      Price to Sales Ratio 24.35
      Price to Cash Ratio 17.4
      Price to Book Ratio 4.84
      Dividend Yield -

      Share Statistics

      Shares Outstanding 61.11M
      Average Volume (1 week) 482.55k
      Average Volume (1 Month) 472.4k
      52 Week Change 21.96%
      52 Week High 45.31
      52 Week Low 9.60
      Spread (Intraday) 29.2 (73%)

      Company Info

      Company Name Kymera Therapeutics Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.kymeratx.com
      Industry biological pds,ex diagnstics (2836)